Allogene Therapeutics, Inc. (ALLO) Tops Q4 EPS by 4c
Tweet
Share
E-mail
Get Alerts ALLO Hot Sheet
Join SI Premium – FREE
Allogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q4 EPS of ($0.28), $0.04 better than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vail Resorts (MTN) 2200 contracts October 145 puts trade into quarter results
- Corteva and Inari settle lawsuit over seed depository access
- William Blair Downgrades Lifecore Biomedical (LFCR) to Market Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
